Local Recurrence Rates in Watchful Waiting for Cutaneous Squamous Cell Carcinoma
The following is a summary of “Oncologic outcomes for invasive squamous cell carcinoma with a...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 158 results for 'Cutaneous squamous cell carcinoma'
AI Predicts Metastases in Cutaneous Squamous Cell Carcinoma
Artificial intelligence accurately predicted metastatic events in patients with cutaneous squamous cell carcinoma (cSCC), according to research published in the Journal of Clinical Oncology. “Whilst rates of metastatic cSCC are...
Read More
Microneedle-assisted transdermal delivery of perfluorotripropylamine-based oxygenated emulsion gel loaded with 5-aminolevulinic acid for enhanced photodynamic therapy of cutaneous squamous cell carcinoma.
Topical photodynamic therapy (TPDT) is a clinical treatment for cutaneous squamous cell carcinoma...
Read More
Multicenter Study of Incomplete Excised Cutaneous Squamous Cell Carcinoma
The following is a summary of “Rate and Characteristics of Incompletely Excised Cutaneous...
Read More
Cutaneous Squamous Cell Carcinoma: Immune Landscape-Dependent Progression
However, the impact of the tumor immune microenvironment on clinical outcomes in head and neck...
Read More
An Analysis of High T-Stage Cutaneous Squamous Cell Carcinomas with Negative Histologic Margins
Although adjuvant radiotherapy (ART) is advised for some high-risk cutaneous squamous cell...
Read More
Risk Factors For Metastatic Cutaneous Squamous Cell Carcinoma (cSCC)
Only in tiny data sets have risk variables for cutaneous squamous cell carcinoma (cSCC) metastasis...
Read More
Randomized Trial for High-risk Cutaneous Squamous Cell Carcinoma Patients Treated With Adjuvant Cemiplimab
High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to...
Read More
Age Associated Mutation in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma was the most frequent type of skin cancer globally. The presence...
Read MoreAdvertisement
Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
In the United States, almost 1.5 million cutaneous squamous cell cancer (cSCC) are identified...
Read More
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Treatment of actinic keratosis (AK) aims to prevent cutaneous squamous cell carcinoma (cSCC)....
Read More
Management of elderly patients with advanced cutaneous squamous cell carcinoma.
The incidence of cutaneous squamous cell carcinoma has been increasing rapidly in recent years,...
Read More
Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (CSCC) is one of the most common types of cancer in humans, and...
Read MoreReal world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Cutaneous squamous cell carcinoma (cSCC) has an overall favourable outcome, except for patients with an advanced stage disease. The programmed death protein-1 (PD-1) inhibitor cemiplimab has been approved for use in advanced...
Read More
Cohort and Nested Case-Control Study of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients, by Medication.
Knowledge is needed about squamous cell carcinoma (cSCC) risk in solid organ transplant recipients...
Read More
Cutaneous Beta-HPV May Up Risk for Cutaneous Squamous Cell Carcinoma
WEDNESDAY, Aug. 11, 2021 (HealthDay News) — Cutaneous beta-human papillomavirus (HPV) may...
Read More
Cutaneous Beta-HPV May Up Risk for Cutaneous Squamous Cell Carcinoma
WEDNESDAY, Aug. 11, 2021 (HealthDay News) — Cutaneous beta-human papillomavirus (HPV) may...
Read More
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 Study): an open-label, nonrandomized, multicenter, phase 2 trial.
Pembrolizumab demonstrated clinically meaningful and durable antitumor activity with a manageable...
Read More
Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
The last revision of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual included...
Read More
Basement Membrane’s Role In Cutaneous Squamous Cell Carcinoma(cSSC)
The basement membrane separates the epidermis from the dermis. Squamous cell carcinoma (cSSC) is...
Read More